<italic toggle="yes">In Vivo</italic> Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
ABSTRACT Protease inhibitors (PIs) are the second- and last-line therapy for the majority of HIV-infected patients worldwide. Only around 20% of individuals who fail PI regimens develop major resistance mutations in protease. We sought to explore the role of mutations in gag-pro genotypic and phenot...
Guardado en:
Autores principales: | Rawlings Datir, Steven Kemp, Kate El Bouzidi, Petra Mlchocova, Richard Goldstein, Judy Breuer, Greg J. Towers, Clare Jolly, Miguel E. Quiñones-Mateu, Patrick S. Dakum, Nicaise Ndembi, Ravindra K. Gupta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7199b87aeca649fba51303efebde939d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
<italic toggle="yes">Toxoplasma</italic> Cathepsin Protease B and Aspartyl Protease 1 Are Dispensable for Endolysosomal Protein Digestion
por: Christian McDonald, et al.
Publicado: (2020) -
Cuts Both Ways: Proteases Modulate Virulence of Enterohemorrhagic <italic toggle="yes">Escherichia coli</italic>
por: Lauren D. Palmer, et al.
Publicado: (2019) -
Protease-Mediated Growth of <named-content content-type="genus-species">Staphylococcus aureus</named-content> on Host Proteins Is <italic toggle="yes">opp3</italic> Dependent
por: McKenzie K. Lehman, et al.
Publicado: (2019) -
Protease Inhibitor and Metabolic Alteration
por: Cavenaghi,F. M, et al.
Publicado: (2012) -
Serum-Mediated Cleavage of <italic toggle="yes">Bacillus anthracis</italic> Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase
por: David L. Goldman, et al.
Publicado: (2018)